LU80795A1 - Nouveaux derives de thienohydantoine et composition pharmaceutique les contenant - Google Patents
Nouveaux derives de thienohydantoine et composition pharmaceutique les contenantInfo
- Publication number
- LU80795A1 LU80795A1 LU80795A LU80795A LU80795A1 LU 80795 A1 LU80795 A1 LU 80795A1 LU 80795 A LU80795 A LU 80795A LU 80795 A LU80795 A LU 80795A LU 80795 A1 LU80795 A1 LU 80795A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- thienohydantoine
- derivatives
- new
- pharmaceutical composition
- composition containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/870,542 US4127665A (en) | 1978-01-18 | 1978-01-18 | Thienohydantoin derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU80795A1 true LU80795A1 (fr) | 1979-09-07 |
Family
ID=25355609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU80795A LU80795A1 (fr) | 1978-01-18 | 1979-01-16 | Nouveaux derives de thienohydantoine et composition pharmaceutique les contenant |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4127665A (xx) |
| JP (1) | JPS54109975A (xx) |
| BE (1) | BE873500A (xx) |
| DE (1) | DE2901477C2 (xx) |
| DK (1) | DK151260C (xx) |
| FR (1) | FR2415112A1 (xx) |
| GB (1) | GB2012759B (xx) |
| IE (1) | IE47726B1 (xx) |
| IT (1) | IT1110007B (xx) |
| LU (1) | LU80795A1 (xx) |
| NL (1) | NL176459B (xx) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4147797A (en) * | 1978-08-11 | 1979-04-03 | Pfizer Inc. | Spiro-furanohydantoin derivatives |
| US4181728A (en) * | 1978-11-16 | 1980-01-01 | Pfizer Inc. | Spiro-polycyclicimidazolidinedione derivatives |
| US4181729A (en) * | 1979-03-21 | 1980-01-01 | Pfizer Inc. | Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives |
| US4210667A (en) * | 1979-04-19 | 1980-07-01 | Pfizer Inc. | Pharmaceutical preparations containing coumarin carboxylic acid derivatives |
| US4490381A (en) * | 1979-11-13 | 1984-12-25 | Imperial Chemical Industries Plc | 1'-Substituted spiro[imidazolidine-4,3'-indoline]2,2',5-triones |
| EP0065393B1 (en) * | 1981-05-12 | 1984-12-27 | Imperial Chemical Industries Plc | Pyrrole derivatives |
| US4464385A (en) * | 1982-04-15 | 1984-08-07 | Alcon Laboratories, Inc. | Treatment of diabetic complications with hydantoins |
| US4540700A (en) * | 1982-04-15 | 1985-09-10 | Alcon Laboratories, Inc. | Treatment of diabetic complications with certain spiro-imidazolidine-diones |
| US4436745A (en) | 1982-04-15 | 1984-03-13 | Alcon Laboratories, Inc. | Method of inhibiting aldose reductase activity |
| US4438272A (en) | 1982-04-15 | 1984-03-20 | Alcon Laboratories, Inc. | Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones |
| US5070100A (en) * | 1983-09-14 | 1991-12-03 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives |
| US4864028A (en) * | 1983-09-14 | 1989-09-05 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives |
| US4537892A (en) * | 1983-09-14 | 1985-08-27 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase |
| US5153211A (en) * | 1983-09-14 | 1992-10-06 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase |
| US4680306A (en) * | 1984-07-20 | 1987-07-14 | Pfizer Inc. | Sprio-imidazolones for treatment of diabetes complications |
| US4966911A (en) * | 1984-11-20 | 1990-10-30 | Washington Research Foundation | Immunoregulatory agents |
| US5340829A (en) * | 1984-11-20 | 1994-08-23 | Washington Research Foundation | Immunoregulatory agents |
| JP2708507B2 (ja) * | 1988-04-07 | 1998-02-04 | 株式会社三和化学研究所 | （ｄ）‐６‐フルオロ‐２，３‐ジヒドロ‐２’，５’‐ジオキソ‐スピロ［４Ｈ‐１‐ベンゾピラン‐４，４’‐イミダゾリジン］‐２‐カルボキサミド誘導体、これらの製法及び用途 |
| JPH05508386A (ja) * | 1989-02-10 | 1993-11-25 | ワシントン リサーチ ファンデション | 免疫調整剤 |
| NZ731621A (en) | 2009-12-04 | 2019-01-25 | Sunovion Pharmaceuticals Inc | Multicyclic compounds and methods of use thereof |
| KR20190065246A (ko) | 2016-07-29 | 2019-06-11 | 선오비온 파마슈티컬스 인코포레이티드 | 화합물 및 조성물 및 이들의 용도 |
| IL264446B1 (en) | 2016-07-29 | 2024-05-01 | Pgi Drug Discovery Llc | Compounds and compositions and their use |
| IL268694B2 (en) | 2017-02-16 | 2023-10-01 | Sunovion Pharmaceuticals Inc | Treatment of schizophrenia |
| EP3661929B1 (en) | 2017-08-02 | 2021-07-14 | Sunovion Pharmaceuticals Inc. | Isochroman compounds and uses thereof |
| WO2019161238A1 (en) | 2018-02-16 | 2019-08-22 | Sunovion Pharmaceuticals Inc. | Salts, crystal forms, and production methods thereof |
| AU2020236225A1 (en) | 2019-03-14 | 2021-09-16 | Sunovion Pharmaceuticals Inc. | Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof |
| US11738002B2 (en) | 2020-04-14 | 2023-08-29 | Sunovion Pharmaceuticals Inc. | Methods of treating neurological and psychiatric disorders |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB796069A (en) * | 1955-12-23 | 1958-06-04 | Ici Ltd | Substituted hydantoins |
| DE1135915B (de) * | 1961-06-29 | 1962-09-06 | Asta Werke Ag Chem Fab | Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine |
| CA1088945A (en) * | 1976-10-18 | 1980-11-04 | Pfizer Limited | Hydantoin derivatives as therapeutic agents |
-
1978
- 1978-01-18 US US05/870,542 patent/US4127665A/en not_active Expired - Lifetime
-
1979
- 1979-01-16 BE BE0/192915A patent/BE873500A/xx not_active IP Right Cessation
- 1979-01-16 DE DE2901477A patent/DE2901477C2/de not_active Expired
- 1979-01-16 LU LU80795A patent/LU80795A1/xx unknown
- 1979-01-17 JP JP444379A patent/JPS54109975A/ja active Granted
- 1979-01-17 IT IT19369/79A patent/IT1110007B/it active
- 1979-01-17 FR FR7901155A patent/FR2415112A1/fr active Granted
- 1979-01-17 GB GB791692A patent/GB2012759B/en not_active Expired
- 1979-01-17 NL NLAANVRAGE7900354,A patent/NL176459B/xx not_active IP Right Cessation
- 1979-01-17 DK DK019579A patent/DK151260C/da not_active IP Right Cessation
- 1979-01-30 IE IE88/79A patent/IE47726B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL176459B (nl) | 1984-11-16 |
| BE873500A (fr) | 1979-07-16 |
| GB2012759A (en) | 1979-08-01 |
| DK151260B (da) | 1987-11-16 |
| FR2415112A1 (fr) | 1979-08-17 |
| FR2415112B1 (xx) | 1983-01-14 |
| JPS54109975A (en) | 1979-08-29 |
| JPS612067B2 (xx) | 1986-01-22 |
| IE790088L (en) | 1979-07-18 |
| GB2012759B (en) | 1982-05-26 |
| DK19579A (da) | 1979-07-19 |
| NL7900354A (nl) | 1979-07-20 |
| IT1110007B (it) | 1985-12-23 |
| DE2901477A1 (de) | 1979-07-19 |
| DE2901477C2 (de) | 1982-06-09 |
| IE47726B1 (en) | 1984-05-30 |
| DK151260C (da) | 1988-05-09 |
| US4127665A (en) | 1978-11-28 |
| IT7919369A0 (it) | 1979-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU80795A1 (fr) | Nouveaux derives de thienohydantoine et composition pharmaceutique les contenant | |
| BE876732A (fr) | Nouveaux aminothiazoles et composition pharmaceutique les contenant | |
| BE859824A (fr) | Nouveaux derives d'hydantoine et composition pharmaceutique les contenant | |
| BE867727A (fr) | Nouveaux composes de phtalazine et composition pharmaceutique les contenant | |
| MC1300A1 (fr) | Proteines purifiees,procede de preparation et compositions pharmaceutiques les contenant | |
| BE867248A (fr) | Nouveaux isomeres dextrogyres de spiro-hydantoines asymetriques et compositions pharmaceutiques les contenant | |
| BE873973A (fr) | Derives de metronidazole et compositions pharmaceutiques en contenant | |
| BE871907A (fr) | Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et medicament les contenant | |
| LU78330A1 (fr) | Procede de preparation de nouveaux derives d'hydantoine et de composition pharmaceutique les contenant | |
| BE892805A (fr) | Cycloalcanes substitues et compositions pharmaceutiques les contenant | |
| BE887970A (fr) | Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives | |
| BE858605A (fr) | Nouveaux acides 5-alkoxymidazo (1,2-a)quinoleine-2-carboxyliques et leurs derives et composition pharmaceutique les contenant | |
| FR2353530A1 (fr) | Nouveaux derives de guanidine, leur procede de preparation et composition pharmaceutique les contenant | |
| BE880065A (fr) | Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant | |
| FR2345450A1 (fr) | Quinoxalinones et quinoxalines, leurs procedes de preparation et composition pharmaceutique les contenant | |
| BE871623A (fr) | Nouveaux derives du tetrazole et compositions pharmaceutiques les contenant | |
| FR2446819B1 (fr) | Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant | |
| BE811856A (fr) | Nouveaux derives de quinazoline et composition pharmaceutique les contenant | |
| FR2331339A1 (fr) | Nouveaux composes heterocycliques et composition pharmaceutique les contenant | |
| FR2333496A2 (fr) | Nouveaux derives d'ethanolamine, leur procede de preparation et composition pharmaceutique les contenant | |
| FR2352790A1 (fr) | Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant | |
| FR2450814B1 (fr) | 24,24-difluoro-25-hydroxycholecalciferol et composition pharmaceutique renfermant ce produit | |
| FR2303559A1 (fr) | Nouveaux derives d'histidine, leur procede de preparation et composition pharmaceutique les contenant | |
| FR2329281A1 (fr) | Nouveaux 6,8-dioxamorphinanes n-substitues et composition pharmaceutique les contenant | |
| BE815584A (fr) | Nouveaux 3-alkyl-9-aminoalkyl-1,2,3,4-tetra-hydrocarbazoles et composition pharmaceutique les contenant |